Supplement use during an intergroup clinical trial for breast cancer (S0221)

Breast Cancer Research and Treatment

Volumn 137, Issue 3, 2013, Pages 903-913

  Zirpoli, Gary R ^a   Brennan, Patrick M ^a   Hong, Chi Chen ^a   McCann, Susan E ^a   Ciupak, Gregory ^a   Davis, Warren ^a   Unger, Joseph M ^b   Thomas Budd, G ^c   Hershman, Dawn L ^d   Moore, Halle C F ^c   Stewart, James ^e   Isaacs, Claudine ^f   Hobday, Timothy ^g   Salim, Muhammad ^h   Hortobagyi, Gabriel N ⁱ   Gralow, Julie R ^j   Albain, Kathy S ^k   Ambrosone, Christine B ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b USA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Columbia University ^*  (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f GEORGETOWN UNIVERSITY   (United States)

^g MAYO CLINIC   (United States)

^h Allan Blair Cancer Centre   (Canada)

ⁱ UNIVERSITY OF TEXAS   (United States)

^j SEATTLE CANCER CARE ALLIANCE   (United States)

^k LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

more..

Author keywords

Antioxidants; Breast cancer; Chemotherapy; Dietary supplements; Epidemiology

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; CYANOCOBALAMIN; FOLIC ACID; MULTIVITAMIN; PYRIDOXINE; VITAMIN D; ANTINEOPLASTIC AGENT; ANTIOXIDANT; VITAMIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RISK; CLINICAL STUDY; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; VITAMIN SUPPLEMENTATION; BREAST TUMOR; DIET SUPPLEMENTATION; MIDDLE AGED; RISK; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BREAST NEOPLASMS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; RISK FACTORS; VITAMINS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84879362365     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2400-2     Document Type: Article

References (21)

1. Radimer K, Bindewald B, Hughes J et al (2004) Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 160:339-349. doi: 10.1093/aje/kwh207
2. Rock CL (2007) Multivitamin-multimineral supplements: who uses them? Am J Clin Nutr 85:277-279
3. Rock CL, Newman VA, Neuhouser ML et al (2004) Antioxidant supplement use in cancer survivors and the general population. J Nutr 134:3194-3195
4. Newman V, Rock CL, Faerber S et al (1998) Dietary supplement use by women at risk for breast cancer recurrence. The women's healthy eating and living study group. J Am Diet Assoc 98:285-292
5. Greenlee H, Gammon MD, Abrahamson PE et al (2009) Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the long Island breast cancer study project. Cancer 115:3271-3282. doi: 10.1002/cncr.24378
6. Ambrosone CB, Ahn J, Schoenenberger V (2005) Antioxidant supplements, genetics and chemotherapy outcomes. Curr Cancer Ther Rev I:251-258
7. Lawenda BD, Kelly KM, Ladas EJ et al (2008) Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 100:773-783. doi: 10.1093/jnci/djn148
8. Norman HA, Butrum RR, Feldman E et al (2003) The role of dietary supplements during cancer therapy. J Nutr 133:3794-3799
9. American Institute for Cancer Research (2000) Nutrition of the cancer patient. Washington, DC
10. Cassileth BR, Vickers AJ (2005) High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care. J Clin Oncol 23:2590-2592. doi: 10.1200/JCO.2005.11.922
11. Greenlee H, Kwan ML, Kushi LH et al (2012) Antioxidant supplement use after breast cancer diagnosis and mortality in the life after cancer epidemiology (LACE) cohort. Cancer 118:2048-2058. doi: 10.1002/cncr.26526
12. Mehta DH, Gardiner PM, Phillips RS et al (2008) Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions. J Altern Complement Med 14:1263-1269. doi: 10.1089/acm.2008.0290
13. Ashikaga T, Bosompra K, O'Brien P et al (2002) Use of complementary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Supportive care in cancer: official journal of the multinational association of supportive care in cancer 10:542-548. doi: 10.1007/s00520-002-0356-1
14. Rausch SM, Winegardner F, Kruk KM et al (2011) Complementary and alternative medicine: use and disclosure in radiation oncology community practice. Supportive care in cancer: official journal of the multinational association of supportive care in cancer 19:521-529. doi: 10.1007/s00520-010- 0846-5
15. Ferrucci LM, McCorkle R, Smith T et al (2009) Factors related to the use of dietary supplements by cancer survivors. J Altern Complement Med 15:673-680. doi: 10.1089/acm.2008.0387
16. Kwan D, Hirschkorn K, Boon H (2006) U.S. and Canadian pharmacists' attitudes, knowledge, and professional practice behaviors toward dietary supplements: a systematic review. BMC Complement Altern Med 6:31. doi: 10.1186/1472-6882-6-31
17. Roth M, Lin J, Kim M et al (2009) Pediatric oncologists' views toward the use of complementary and alternative medicine in children with cancer. Journal of Pediatric Hematology/Oncology: official journal of the American Society of Pediatric Hematology/Oncology 31:177-182. doi: 10.1097/MPH.0b013e3181984f5a
18. Satia-Abouta J, Patterson RE, King IB et al (2003) Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study. Am J Epidemiol 157:944-954. doi: 10.1093/aje/kwg039
19. Greenlee H, Hershman DL, Jacobson JS (2009) Use of antioxidant supplements during breast cancer treatment: a comprehensive review. Breast Cancer Res Treat 115:437-452. doi: 10.1007/s10549-008-0193-0
20. Ng K, Meyerhardt JA, Chan JA et al (2010) Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803. Journal of Clinical Oncology: official journal of the American Society of Clinical Oncology 28:4354-4363. doi: 10.1200/JCO.2010.28.0362
21. Nechuta S, Lu W, Chen Z et al (2011) Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 20:262-271. doi: 10.1158/1055-9965.EPI-10-1072